-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Exponent, Lowers Price Target to $75

Benzinga·05/01/2026 21:31:38
Listen to the news
UBS analyst Joshua Chan maintains Exponent (NASDAQ:EXPO) with a Neutral and lowers the price target from $85 to $75.